STAT Plus: Biotech faces a crisis in credibility fueled by boom-era hubris
XAVIER LEOTY/AFP/GETTY IMAGES
Industry executives seem to be forgetting that it is far better to underpromise and overdeliver than the other way around.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario